These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 29608706

  • 1. Risks and outcomes of invasive fungal infections in pediatric allogeneic hematopoietic stem cell transplant recipients receiving fluconazole prophylaxis: a multicenter cohort study by the Turkish Pediatric Bone Marrow Transplantation Study Group.
    Hazar V, Karasu GT, Uygun V, Öztürk G, Kiliç SÇ, Küpesiz A, Daloglu H, Aksoylar S, Atay D, Ince EÜ, Karakükçü M, Özbek N, Tayfun F, Kansoy S, Özyürek E, Akçay A, Gürsel O, Haskologlu S, Kaya Z, Yilmaz S, Tanyeli A, Yesilipek A.
    Med Mycol; 2019 Feb 01; 57(2):161-170. PubMed ID: 29608706
    [Abstract] [Full Text] [Related]

  • 2. Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience.
    Busca A, Cinatti N, Gill J, Passera R, Dellacasa CM, Giaccone L, Dogliotti I, Manetta S, Corcione S, De Rosa FG.
    Front Cell Infect Microbiol; 2021 Feb 01; 11():805514. PubMed ID: 35071052
    [Abstract] [Full Text] [Related]

  • 3. Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients.
    Park S, Kim K, Jang JH, Kim SJ, Kim WS, Chung DR, Kang CI, Peck KR, Jung CW.
    J Infect; 2016 Nov 01; 73(5):496-505. PubMed ID: 27394404
    [Abstract] [Full Text] [Related]

  • 4. Fungal infections in hematopoietic stem cell transplantation in children at a pediatric children's hospital in Argentina.
    Gomez SM, Caniza M, Fynn A, Vescina C, Ruiz CD, Iglesias D, Sosa F, Sung L.
    Transpl Infect Dis; 2018 Aug 01; 20(4):e12913. PubMed ID: 29679436
    [Abstract] [Full Text] [Related]

  • 5. Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation.
    Liu YC, Chien SH, Fan NW, Hu MH, Gau JP, Liu CJ, Yu YB, Liu CY, Hsiao LT, Liu JH, Chiou TJ, Chen PM, Tzeng CH.
    J Microbiol Immunol Infect; 2016 Aug 01; 49(4):567-74. PubMed ID: 25735797
    [Abstract] [Full Text] [Related]

  • 6. A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogeneic stem cell transplantation from a HLA identical sibling.
    Sarina B, Mariotti J, Bramanti S, Morabito L, Crocchiolo R, Rimondo A, Tordato F, Pocaterra D, Casari E, De Philippis C, Carlo-Stella C, Santoro A, Castagna L.
    Transpl Infect Dis; 2018 Aug 01; 20(4):e12906. PubMed ID: 29668124
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-Lasting Protective Effect of Posaconazole Prophylaxis in Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
    Busca A, Candoni A, Audisio E, Passera R, Bruno B, Monaco F, Mordini N, Vacca A, Delia M, Aversa F, Pagano L.
    Biol Blood Marrow Transplant; 2016 Dec 01; 22(12):2214-2219. PubMed ID: 27667012
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Invasive Fungal Infections in Immunocompromised Children: Novel Insight Following a National Study.
    Olivier-Gougenheim L, Rama N, Dupont D, Saultier P, Leverger G, AbouChahla W, Paillard C, Gandemer V, Theron A, Freycon C, Pluchart C, Blouin P, Pellier I, Thouvenin-Doulet S, Desplantes C, Ducassou S, Oudot C, Rouger-Gaudichon J, Cheikh N, Poiree M, Schneider P, Plat G, Contet A, Rialland F, Gouache E, Brethon B, Bertrand Y, Domenech C.
    J Pediatr; 2021 Sep 01; 236():204-210. PubMed ID: 33991540
    [Abstract] [Full Text] [Related]

  • 11. Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Rosillo C, Avila AM, Huang YT, Devlin S, Cho C, Montoro J, Maloy MA, Papanicolaou GA, Barba P, Perales MA.
    Transpl Infect Dis; 2018 Aug 01; 20(4):e12897. PubMed ID: 29668073
    [Abstract] [Full Text] [Related]

  • 12. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K, Nishida T, Asano-Mori Y, Oshima K, Ohashi K, Mori T, Kanamori H, Miyamura K, Kato C, Kobayashi N, Uchida N, Nakamae H, Ichinohe T, Morishima Y, Suzuki R, Yamaguchi T, Fukuda T.
    Biol Blood Marrow Transplant; 2015 Nov 01; 21(11):2008-16. PubMed ID: 26211985
    [Abstract] [Full Text] [Related]

  • 13. Risk factors for invasive fungal infections after haematopoietic stem cell transplantation: a systematic review and meta-analysis.
    Biyun L, Yahui H, Yuanfang L, Xifeng G, Dao W.
    Clin Microbiol Infect; 2024 May 01; 30(5):601-610. PubMed ID: 38280518
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients with invasive fungal infection.
    Pepeler MS, Yildiz Ş, Yegin ZA, Özkurt ZN, Tunçcan ÖG, Erbaş G, Köktürk N, Kalkanci A, Yildirim Z.
    J Infect Dev Ctries; 2018 Sep 30; 12(9):799-805. PubMed ID: 31999640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.